- Home
- MRVI vs ECX Comparison
MRVI vs ECX Comparison
Compare MRVI & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- ECX
- Stock Information
- Founded
- MRVI 2014
- ECX 2017
- Country
- MRVI United States
- ECX China
- Employees
- MRVI N/A
- ECX N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- ECX EDP Services
- Sector
- MRVI Health Care
- ECX Technology
- Exchange
- MRVI Nasdaq
- ECX Nasdaq
- Market Cap
- MRVI 262.9M
- ECX 313.1M
- IPO Year
- MRVI 2020
- ECX N/A
- Fundamental
- Price
- MRVI $2.12
- ECX $1.80
- Analyst Decision
- MRVI Hold
- ECX Strong Buy
- Analyst Count
- MRVI 9
- ECX 1
- Target Price
- MRVI $6.54
- ECX $3.20
- AVG Volume (30 Days)
- MRVI 1.7M
- ECX 7.0M
- Earning Date
- MRVI 05-12-2025
- ECX 04-30-2025
- Dividend Yield
- MRVI N/A
- ECX N/A
- EPS Growth
- MRVI N/A
- ECX N/A
- EPS
- MRVI N/A
- ECX N/A
- Revenue
- MRVI $259,185,000.00
- ECX $805,604,079.00
- Revenue This Year
- MRVI N/A
- ECX $33.33
- Revenue Next Year
- MRVI $11.14
- ECX $27.61
- P/E Ratio
- MRVI N/A
- ECX N/A
- Revenue Growth
- MRVI N/A
- ECX 21.06
- 52 Week Low
- MRVI $1.67
- ECX $0.76
- 52 Week High
- MRVI $11.56
- ECX $3.25
- Technical
- Relative Strength Index (RSI)
- MRVI 50.73
- ECX 63.16
- Support Level
- MRVI $1.96
- ECX $1.38
- Resistance Level
- MRVI $2.16
- ECX $1.67
- Average True Range (ATR)
- MRVI 0.12
- ECX 0.17
- MACD
- MRVI 0.04
- ECX 0.10
- Stochastic Oscillator
- MRVI 65.31
- ECX 94.12
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.